Interview with a scientist: traffic jams at the nuclear pores.
Dysfunctional nuclear-cytoplasmic trafficking of RNA binding proteins might contribute to neurological disorders. For this blog post we spoke with Dr. Rita Sattler.She employs human patient-derived induced pluripotent stem cells to elucidate the nuclear-cytoplasmic trafficking mechanisms in neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
Learn MoreTopics:
Antibody Validation / Immunohistochemistry / interview / atlasantibodies